We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
$50 for your first 3 months Get the print edition and steer from crisis to recovery
Add this topic to your myFT Digest for news straight to your inbox
New models are emerging to allow pharma companies to turn a profit regardless of how much new antibiotics are used
Recommendations from an FT roundtable with pharma, government, and NGO experts
A South African doctor’s prescription to stop poorer countries losing access to many of modern medicine’s advances
Household names like McDonald’s start to modify practices to aid farm animals’ health, growth and digestion
Chemicals company makes largest donation for science in university’s history
Detailed information is starting to emerge on the problem and how to combat it
Some hospital schemes encourage proper antimicrobial stewardship but progress has been slow
Promising treatments in pipeline despite lack of financial incentives for pharma industry
Amundi and Aviva among backers of initiative targeting food, retail and pharmaceutical groups
Over half a century after antibiotics revolutionised medicine, overuse threatens existing treatments while the pipeline of replacements is thin
How can we stop the next global health crisis?
The FT is working with the Wellcome Trust to raise awareness of a growing threat
Covid-19 is a warning that we must develop drugs to treat future threats
Twenty-three companies join forces to launch a fund to develop new antibiotics by 2030
Covid-19 is just the latest outbreak linked to livestock harming agriculture investment
International Edition
